Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
L656553-1ml
|
1ml |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$165.90
|
|
| Specifications & Purity | 10mM in DMSO |
|---|---|
| Biochemical and Physiological Mechanisms | LDHA-IN-3, as a selenobenzene compound, is a potent, noncompetitive lactate dehydrogenase ( LDHA ) inhibitor ( IC 50 =145.2 nM). LDHA-IN-3 can be used for the research of cancer. |
| Storage Temp | Store at -80°C |
| Shipped In |
Ice chest + Ice pads This product requires cold chain shipping. Ground and other economy services are not available. |
| Product Description |
LDHA-IN-3, as a selenobenzene compound, is a potent, noncompetitive lactate dehydrogenase ( LDHA ) inhibitor ( IC 50 =145.2 nM). LDHA-IN-3 can be used for the research of cancer In Vitro PSTMB (0~500 μM; 48 hours; MCF-7 cells) shows cytotoxic effect. PSTMB (0.01~1 μM) shows dose-dependent inhibition of LDHA activity. PSTMB (0~0.5 μM) inhibits LDHA activity in Michaelis-Menten and Lineweaver-Burk plots. PSTMB (30 and 50 μM; HT29 cells) induces ROS production and mitochondrial damage. PSTMB can bind to LDHA protein efficiently. PSTMB induces the intrinsic pathway-mediated apoptosis of cancer cells via production of mitochondrial ROS. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: MCF-7 cells Concentration: 0~500 μM Incubation Time: 48 hours Result: Showed cytotoxic effect. IC50& Target:IC50: 145.2 nM (LDHA) |
| Smiles | FC(C1=CC=C([Se]C2=CC=CC=C2)C=C1)(F)F |
|---|---|
| Molecular Weight | 301.17 |